13-067 Code Vt. R. 13-140-067-X

Current through August, 2024
Section 13 140 067 - STANDARD PROTOCOL AND PROCEDURES FOR INITIATING AND DISPENSING EMERGENCY CONTRACEPTION BY PHARMACISTS
Section 1.1 Introduction
(a) 26 V.S.A. Chapter 36, Subchapter 7 authorizes licensed pharmacists who have entered a Collaborative Practice Agreement with a physician or other prescriber to initiate and dispense emergency contraception. They may do so pursuant to the protocol set forth below. These rules, forms, and documents adopted herein implement that legislative directive.
(b) Copies of all documents required as part of the emergency contraception protocol and procedures may be obtained from the Department of Health through its website (http://healthvermont.gov) or the Board of Pharmacy through its website (http://vtprofessionals. org/ [File Link Not Available])
(c) Adopted as part of these rules are the following forms:
(1) Form A -- Vermont Prescriber/Pharmacist Collaborative Practice Agreement and Protocol for Dispensing Emergency Contraception
(2) Form B -- Emergency Contraception: Client Informed Consent and Referral
(3) Form C -- Emergency Contraception: Key Facts and Instructions for Use in Vermont
Section 1.2 Emergency Contraception Pharmacist Education Program

Prior to initiating emergency contraception drug therapy, a pharmacist must complete an emergency contraception therapy training and education program which is specifically approved by the Vermont Board of Pharmacy as a precondition to entering a Vermont Collaborative Practice Agreement. Only then may the pharmacist enter into a Collaborative Practice Agreement with a physician or other prescriber.

Section 1.3 Collaborative Practice Agreements: Requirements

A pharmacist and physician or other prescriber may enter into a Collaborative Practice Agreement as set forth in Form A. The Agreement sets forth the purpose, limits, and intent of the collaboration.

Section 1.4 Emergency Contraception Collaborative Practice Agreement
(a) The Emergency Contraception Collaborative Practice Agreement must be signed and dated by the prescriber and the pharmacist to be valid.
(b) By executing the Collaborative Practice Agreement, both the pharmacist and the authorized prescriber agree and acknowledge that:
(1) The licensed pharmacist shall provide the client with drug information concerning dosage, potential adverse side effects, and follow-up contraceptive care as set forth in the forms and documents adopted as part of these rules.
(2) The Collaborative Practice Agreement shall remain in effect for up to two years and may be renewed for two year periods thereafter, unless terminated prior to that time in writing by either the pharmacist or authorized prescriber.
(3) Termination must be by written notice to the other.
(4) Two copies of the Collaborative Practice Agreement will be sent to the Board of Pharmacy who will keep a copy on file and send a copy to the Vermont Department of Health.
(5) The pharmacist will notify both the Board of Pharmacy and the prescriber if the pharmacist moves to a different practice site during the period of the Collaborative Practice Agreement.
(c) When the Collaborative Practice Agreement expires or is rescinded, the licensed pharmacist shall not have authority to initiate and dispense emergency contraceptives until another Collaborative Practice Agreement is executed.
Section 1.5 Emergency Contraception: Client Informed Consent and Referral

For each client seeking emergency contraception, the pharmacist shall complete a Client Informed Consent and Referral (Form B). The Informed Consent and Referral shall be signed by both the client and the licensed pharmacist.

Section 1.6 Labels for Emergency Contraception

In addition to information required by law, the prescription label placed on the drug therapy product shall identify:

1) the collaborating physician or other prescriber and
2) the pharmacist authorized to initiate and dispense emergency contraception.
Section 1.7 Documents to be Provided by Pharmacist

For each emergency contraception drug therapy initiated pursuant to this protocol, the pharmacist shall provide the client receiving the emergency contraceptive drug with the following original/photocopy:

(a) "Emergency Contraception: Client Informed Consent and Referral" (Form B)
(b) "Emergency Contraception: Key Facts and Instructions for Use" (Form C)
Section 1.8 Client Records
(a) Each emergency contraception therapy prescription authorized herein shall be documented in a client profile.
(b) The Client Informed Consent and Referral (Form B) is considered a "client record" and is subject to client record retention requirements prescribed by law.
(c) Nothing in these rules shall affect the requirements of existing law relating to maintaining the confidentiality of medical records.
Section 1.9 Duties of Collaborating Pharmacists

In addition to the other requirements set forth in these rules, the collaborating pharmacist shall be sensitive to the privacy and emotional needs of those seeking emergency contraception. The collaborating pharmacist shall be aware of Vermont state law reporting requirements relating to vulnerable individuals.

Form A. Pharmacist/Prescriber Collaborative Practice Agreement and Protocol.

I, , as a licensed health care provider authorized to prescribe medications in the State of Vermont, authorize , R.Ph./Pharm D to initiate emergency contraception drug therapy according to the protocol that follows. The protocol provides written guidelines for initiating drug therapy in accordance with the statutes and regulations of the State of Vermont.

Purpose: Provide access to emergency contraception within the required time frame and to ensure the client receives adequate information to successfully complete therapy.

Procedure: When the client requests emergency contraception (EC) drug therapy, the pharmacist will assess the need for EC drug therapy and will dispense EC drug therapy, as agreed with the health care provider regarding the type, timing, and dosage, according to the protocol established in this agreement and according to the practices recommended in the pharmacist training as approved by the Vermont Board of Pharmacy.

Referrals: If EC drug therapy services are not available at the pharmacy, the client will be referred to another EC provider or to a family planning health center. The pharmacist should refer the client to a health care provider or family planning health center if established pregnancy cannot be ruled out.

If there is a concern that the client may have contracted a sexually transmitted infection through unprotected sex, and/or if the client indicates that she has been sexually assaulted, the pharmacist will provide appropriate referral information while providing ECP's. Referrals can be made to health care providers, community clinics, a sexual assault hot line, or a hospital emergency department with a Sexual Assault Nurse Examiner (SANE) program. See Form C.

Prophylactic Provision: The pharmacist may dispense a course of EC drug therapy to a client in advance of the need for emergency contraception. In addition, the pharmacist will counsel the client on available options for regular contraceptive methods or offer to refer the client to a health care provider or family planning health center for additional contraceptive services.

EC Product Selection: The pharmacist will only dispense medication from a list of products approved for emergency contraception and agreed upon as part of this agreement. The pharmacist should seek to provide the most effective EC product to the client. The list will contain EC drug therapies and adjunct medications for nausea and vomiting associated with EC drug therapy. The list will be maintained at the pharmacy and shared by all participants in the agreement. Along with the medications, the client will be provided with information concerning dosing, potential adverse effects, and follow-up contraceptive care.

Documentation and Quality Assurance: Each prescription initiated by the pharmacist will be documented in a client profile as required by law and maintained at the pharmacy. EC drug therapy prescriptions and other client information shall be provided the same confidentiality as all other client records maintained at/by the pharmacy.

Communication with PCP: The pharmacist may, at the request of the client, communicate information to either the client's primary care provider or OB/GYN for purposes of being referred to a practitioner as a new client regarding her care relevant to emergency contraception drug therapy.

On an annual basis (or more often as agreed upon by prescriber and pharmacist) the authorizing prescriber and the pharmacist will perform a quality assurance review of the decisions made according to mutually acceptable criteria.

Other provisions consistent with the intent of 26 V.S.A. § 2079(a):

The pharmacist named below has completed a training program approved by the Vermont Board of Pharmacy covering procedures listed above, the management of the sensitive communications often encountered in emergency contraception, and the appropriate use of referral sources.

Authorized Prescriber Signature: Date:

Authorized Prescriber Printed Name:

Type or Print Full Name

VT Medical License. #: Vt. Medicaid #

DEA # NPI #

Authorized Prescriber's Office Address: (Street Address)

(City) (State) (Zip Code)

Phone #: Fax #: Email:

Licensed Pharmacist Signature: Date:

Licensed Pharmacist Printed Name:

Type or Print Full Name

VT Pharmacist License #: Pharmacist NPI #

Pharmacy Address: (Street Address)

(City) (State) (Zip Code)

Phone #: Fax #: Email:

The name of this collaborating pharmacist will be provided to the Vermont Department of Health for posting on the Vermont Department of Health's website's EC Collaborative Practitioner listing.

If you do not wish to be included in this listing check here:

This agreement must be renewed every two years. The original copy shall be kept with Pharmacist's files along with EC training certification. One copy shall be maintained at the Prescriber's Office. One copy shall be sent to the Vermont Board of Pharmacy/Office of Professional Regulation. The pharmacist participating in a collaborative practice agreement must notify the prescriber and the Board of Pharmacy of any changes in his/her practice site.

Form B. Client Informed Consent and Referral.

Final, May 1, 2007

Client's Name: Phone #:

Address: City: State: Zip:

Date of Birth (Month/Day/Year): / /

I have been given the Emergency Contraception Key Facts and Instructions for Use and have had access to information about EC:

Client's signature Date

Pharmacist's signature Date

I understand that it may be useful to share this treatment information with my regular health care provider and I make the following decision:

No (Do not share)

Yes I request and authorize the release of this information to the following designated provider:

Name of Designated Provider

Provider's Address

For ASAP Referrals: Provider's Phone Number:

Provider's Fax Number:

Client's signature Date

FOR PHARMACIST USE ONLY:

Client provided with: Referral Made for? Additional pharmacist notes/comments:

Key Facts Sheet (Form C) Contraception

Informed Consent

(Form B - this sheet) STI/HIV

EC Product Pregnancy

Plan B TM Primary Care

Other Sexual Assault Child Abuse (Call DCF 1-800-649-5285)

Date: / / Tim

Pharmacist's Signature: R.Ph./Pharm D

Pharmacist:

1) Keep original copy for your records.
2) Give a copy to the client.
3) If release is authorized, give a copy to the designated provider.

Emergency Contraception: Key Facts and Instructions for Use in Vermont

Note: A copy of this form must be given to the client. This fact sheet may not be altered.

Emergency Contraception (EC) is a safe and effective way to prevent pregnancy after sex.

Consider using Emergency Contraception if you didn't use a contraceptive during sex, you think your contraceptive didn't work, or you were sexually assaulted or forced to have intercourse. EC in theory works by stopping the release of an egg from the ovary (ovulation), or it may prevent the union of a sperm and an egg (fertilization), or it may prevent a fertilized egg from attaching to the womb (implantation). EC will not disrupt an established pregnancy.

What are Emergency Contraception pills?

Emergency Contraception pills (ECP's) contain the same medication as regular birth control pills and help to prevent pregnancy. There are two basic types of Emergency Contraception pills:

. Plan B TM progestin-only pills.

. High doses of regular oral contraceptive pills (containing estrogen and progestin).

Don't wait! Take ECP's as soon as possible.

. While it is best to take ECP's within 3 days of unprotected sex, ECP's can be effective for up to 5 days after unprotected sex.

. You should use a birth control method for the remainder of your menstrual cycle and for preventing pregnancy in the future.

. For more information, talk to your pharmacist or health care provider.

ECP's are safe and effective.

. Progestin-only pills reduce the risk of pregnancy by 89 percent.*

. Combined estrogen/progestin pills reduce the risk of pregnancy by 75 percent.*

. For regular, long-term birth control, other contraceptive methods are more effective than EC.

. Emergency Contraception pills do not protect against sexually transmitted infections, including HIV/AIDS.

* EC has been associated with a slight risk of ectopic pregnancy in women who use birth control pills regularly. Call your doctor if you experience severe lower abdominal pain after taking EC.

ECP's won't cause an abortion.

. Emergency Contraception pills are not the same as RU-486 (the abortion pill).

. Emergency Contraception pills are not effective after pregnancy has occurred and cannot interrupt it.

ECP's won't harm a developing fetus.

. If Emergency Contraception pills are taken mistakenly during pregnancy, they will not harm the developing fetus.

. Using Emergency Contraception pills will not affect a woman's ability to become pregnant in the future.

Women can keep pills at home in case of an emergency.

. Many women find it convenient to have Emergency Contraception pills on hand in case of an emergency.

. Medical providers or a participating pharmacist can provide Emergency Contraception pills before they are needed.

Medical follow-up after taking Emergency Contraception pills.

. If you don't experience a normal period within four weeks, you may be pregnant and should see your health care provider or take a pregnancy test.

. It is important to visit your doctor or health care provider if you need a regular birth control method or information about preventing sexually transmitted infections, such as Chlamydia or HIV/AIDS.

Referral Sources

. Call 1-800-489-7273 for help if you have been raped or sexually assaulted.

. Call 1-800-228-7395 for help with domestic violence.

. For medical follow up call your health care provider or community clinic. To find the nearest Planned Parenthood Health Center, call....1-800-230-PLAN (7526)

Form C. Emergency Contraception -- Instructions for Use.

. Swallow the EC pills as soon as possible after receiving the medication from a pharmacist or health care practitioner. EC works better the sooner you use it.

. Some women may feel tired, dizzy, have headaches, or tender breasts. These side effects should go away within a day or two. Non-prescription pain relievers (such as ibuprofen or acetaminophen) can be used for headache or breast tenderness. You may also have some menstrual spotting (small amounts of bleeding -- less than a period) after taking EC. This should go away in a day or two.

You have been given: You have been given:

Oral Contraceptive Pills

Take: Take:

1 pill now and 1 pill in 12 hours

Take pill(s) ASAP and take pill(s) in 12 hours

2 pills as soon as possible

You have been given/advised to take: to prevent nausea. Take this medication 30-60 minutes before your first EC dose (as advised).

. With some types of EC, nausea and vomiting are possible, but not likely. If you vomit after 30 minutes of taking your dose, do not worry. The medication is already in your system. If you vomit before this time period, call your pharmacist -- you may need to take a repeat dose.

. If you are prescribed or advised to use a medication for possible nausea, take that medication as described in the following directions:

Non-prescriptionDrugs:Timing of Administration

> Meclizine Hydrochloride

(Dramamine II, Bonine)

One or two 25 mg tablets 1 hour before first EC dose; repeat if needed in 24 hours

> Diphenhydramine Hydrochloride

(Benadryl)

One or two 25 mg tablets or capsules 1 hour before first EC dose; repeat as needed every 4-6 hours

> Dimenhydrinate

(Dramamine)

One or two 50 mg tablets or 4--8 teaspoons liquid 30 minutes to one hour before first ECP dose; repeat as needed every 4-6 hours

26 V.S.A. § 2079

13-067 Code Vt. R. 13-140-067-X

EFFECTIVE DATE: June 25, 2007 Secretary of State Rule Log # 07-016